NEWS & EVENTS

CATCH UP WITH OUR LATEST NEWS & EVENTS

Capsida Co-Founders Named to Endpoints’ Top 20 Scientists Under 40

Dr. Nick Goeden and Dr. Nick Flytzanis – “the Nicks,” as many of their colleagues…

Capsida Biotherapeutics Announces Appointment of Rayne Waller to Chief Operating Officer

Company creates chief operating officer role and appoints veteran manufacturing and…

PharmaVoice profiles Capsida CEO Peter Anastasiou

Capsida Biotherapeutics CEO Peter Anastasiou aims to bring AAV therapy to reality…

Capsida Biotherapeutics Poised to Capitalize on Industry-leading Gene Therapy Technology With New CEO, CSO, and CTO

Longtime industry executive Peter Anastasiou appointed Chief Executive Officer…

Capsida Technology and Clinical Leadership to Present at Gene Therapy for Neurological Disorders Conference

Capsida Biotherapeutics Inc., a fully integrated biotechnology company creating a…

Capsida Biotherapeutics Unveils Next-Generation Gene Therapy Manufacturing

New 15,000 square-foot facility in Thousand Oaks will enable industry leading…

Capsida Appoints Swati Tole, M.D., as Chief Medical Officer

Clinical development leader will help advance Capsida’s breakthrough AAV gene…

Capsida Biotherapeutics Debuts with $140 Million of Capital

Versant, Westlake Village BioPartners launch next-generation gene therapy company…